Background: The optimal schedule and the need for a booster dose are unclear for
Haemophilus influenzae type b (Hib) conjugate vaccines. We systematically reviewed …

Background: Conjugate vaccines against Haemophilus influenzae type b (Hib) are widely
used. The full implications of Hib vaccination schedule for vaccine effectiveness (VE) are …

Haemophilus influenzae type b (Hib) is an important cause of meningitis and pneumonia in
children. Despite the availability of Hib conjugate vaccine, many countries are still to …

Global coverage of infant Haemophilus influenzae type b (Hib) vaccination has increased
considerably during the past decade, partly due to GAVI Alliance donations of the vaccine to …

Background. The development of a vaccine against Haemophilus influenzae type b (Hib)
was stimulated by its recognition as a major pathogen of early childhood. The first vaccine to …

Prior to widespread vaccination, Haemophilus influenzae type b was a leading cause of
severe childhood bacterial infection, including meningitis, worldwide. Over the last decade …

OBJECTIVE: To review the epidemiology of Haemophilus influenzae type b (Hib) disease,
the first Hib vaccine and its limitations, the characteristics and clinical efficacy of the newer …

Prior to the introduction of vaccines, Haemophilus influenzae type b (Hib) was the most
common cause of bacterial meningitis and an important cause of severe pneumonia in …

Objective. To determine the burden of Haemophilus influenzae type b (Hib) disease, the
safety and immunogenicity of Hib conjugate vaccine, the practicality of combining Hib …

Since the introduction of Haemophilus Influenzae type b (Hib) conjugate vaccines, invasive
Hib disease has strongly declined worldwide, yet continued control of Hib disease remains …